financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Sell Opinion On Adss Of Petroleo Brasileiro S.a.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Sell Opinion On Adss Of Petroleo Brasileiro S.a.
Mar 10, 2024 10:09 PM

12:55 AM EDT, 03/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Our 12-month target price remains US$13, a 5.1x multiple of enterprise value to projected '25 EBITDA, modestly below U.S. supermajor oils. We think a discount is reasonable due to concerns that political interference may result in more capital allocated towards low-return projects. We raise our '24 earnings per ADS estimate by BRL2.02 to BRL18.84 and start '25's at BRL15.10. Q4 earnings per ADS of BRL4.79, vs. BRL 6.65, was BRL0.19 below consensus. Q4 production averaged 2.94 mmboe/d, 1.1% above consensus. Although PBR's bylaws require dividend payments to be at least 45% of free cash flow (down from 60% in 1H '23), this rule only applies if total debt is below US$65B. That metric now stands at US$62.5B, close to the hurdle number, and is up US$9.4B since year-end '22. As a result, PBR's yield (which we estimate at 19.2%) is arguably at risk in our view if debt levels rise even a modest amount (an extra 4%).

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Sell Opinion On Shares Of Edison International
Research Alert: CFRA Maintains Sell Opinion On Shares Of Edison International
Oct 31, 2025
11:30 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target remains $48, 7.8x our 2026 EPS estimate (down $0.05 to $6.08; 2025 estimate remains $6.03), a wide discount to peers based on weaker growth expectations vs. peers...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Dexcom, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Dexcom, Inc.
Oct 31, 2025
11:35 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month target to $77 from $89, about 32x our 2026 EPS, below DXCM's average forward P/E and slightly under MedTech peers. We lift our 2025 EPS by...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Edwards Lifesciences Corporation
Research Alert: CFRA Keeps Buy Opinion On Shares Of Edwards Lifesciences Corporation
Oct 31, 2025
11:40 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target price to $100 from $93, 35x our 2026 EPS and a slight premium to the company's long-term average forward P/E. We lift our 2025 EPS...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Southern Copper Corporation
Research Alert: CFRA Maintains Hold Opinion On Shares Of Southern Copper Corporation
Oct 31, 2025
11:10 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price by $55 to $151, driven by an EV/EBITDA multiple of 14.5x applied to our 2027 EBITDA estimate, which is a premium to SCCO's three-year...
Copyright 2023-2026 - www.financetom.com All Rights Reserved